Company Overview

Integer Holdings Corporation is a global medical device contract development and manufacturing organization that serves original equipment manufacturers (OEMs) across the medical technology and healthcare industries. The company specializes in designing, developing, and manufacturing complex medical devices and components that are used in cardiac and vascular, neuromodulation, advanced surgical, orthopedics, and portable medical applications. Its core value proposition is providing vertically integrated capabilities that support customers from early-stage design through full-scale commercial manufacturing.

The company generates revenue primarily by supplying finished medical devices, sub-assemblies, components, and specialized manufacturing services to established medical device OEMs. Integer is positioned as a long-term strategic partner rather than a commoditized supplier, emphasizing regulatory expertise, quality systems, and deep engineering know-how. Founded in 1914 as Greatbatch Inc. and later renamed Integer Holdings Corporation, the company evolved from a battery-focused manufacturer into a diversified medical device outsourcing platform following a series of strategic acquisitions and portfolio expansions.

Business Operations

Integer operates through integrated business units aligned around major medical technology end markets, with revenue primarily derived from long-term customer contracts. Its principal business segments include Cardio & Vascular, Advanced Surgical, Orthopedics, and Portable Medical, which together encompass implantable devices, catheter-based technologies, surgical instruments, power systems, and wearable or home-use medical devices. The company’s operations span design and development, precision machining, molding, assembly, testing, sterilization, and packaging.

The company maintains both domestic and international manufacturing operations, with assets that include specialized cleanroom facilities, proprietary manufacturing processes, and regulated quality systems compliant with global medical standards. Integer operates through wholly owned subsidiaries and has historically expanded capabilities through acquisitions of specialized medical technology manufacturers, integrating them into its platform to broaden technical depth and customer reach.

Strategic Position & Investments

Integer’s strategic direction centers on organic growth through deeper penetration with existing OEM customers, expansion into higher-growth medical technology categories, and selective acquisitions that enhance technical capabilities or access to attractive end markets. The company prioritizes investment in advanced manufacturing technologies, automation, and engineering services to support increasingly complex medical devices and regulatory requirements.

Historically, Integer has pursued bolt-on acquisitions to strengthen its position in cardiac, neuromodulation, and surgical markets, integrating acquired companies into its broader operating platform. The company continues to focus on emerging medical technologies such as minimally invasive procedures, implantable electronic devices, and next-generation surgical systems, aligning capital allocation with long-term healthcare demand trends.

Geographic Footprint

Integer Holdings Corporation is headquartered in North America, with its corporate headquarters in the United States, and maintains a significant global manufacturing and engineering footprint. The company operates facilities across the United States, Europe, and Asia-Pacific, supporting multinational medical device OEMs with localized production and global supply chain capabilities.

Its international presence allows Integer to serve customers in major healthcare markets while managing regulatory, cost, and logistical considerations. The company’s geographic diversification supports resilience and scalability, with operations strategically located near key customer hubs and medical technology clusters.

Leadership & Governance

Integer is led by an executive team with extensive experience in medical technology, advanced manufacturing, and regulated industries. Leadership emphasizes operational excellence, disciplined capital allocation, and long-term partnerships with customers, guided by a strategic vision focused on sustainable growth and innovation in healthcare manufacturing.

Key executives include:

• Joseph W. Dziedzic – President & Chief Executive Officer
• Payman Khales – Executive Vice President & Chief Financial Officer
• Darren E. Guccione – Executive Vice President & Chief Operating Officer
• Daniel W. Harkin – Executive Vice President & Chief Commercial Officer
• Monica M. Garcia – Senior Vice President, General Counsel & Corporate Secretary

The company operates under a standard public-company governance framework, with oversight provided by an independent board of directors and compliance with U.S. regulatory and reporting requirements.